Stock Information
Belite Bio Inc (BLTE)
Ticker Symbol: BLTE
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $5,302.38 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.6459
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -26.87%
Latest News
-
Belite Bio, Inc (BLTE) Presents at 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026) - Slideshow
Wed, May 27, 2026 7:13 PM
-
Mizuho Maintains Outperform on Belite Bio, Lowers Price Target to $215
Tue, May 26, 2026 1:25 PM
-
Belite Bio, Inc 2026 Q1 - Results - Earnings Call Presentation
Fri, May 22, 2026 7:20 PM
-
HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $200 Price Target
Thu, May 21, 2026 6:42 AM
Key Financials
Financial data not available
